British studies warn of Omicron’s speed, and one notes the need for boosters.


The first real-world study of how vaccines perform against the Omicron variant revealed a significant drop in protection against symptomatic cases caused by the new and rapidly spreading coronavirus.

By BENJAMIN MUELLER | NYTimes Health | Disclosure

Comments